Published June 24, 1981 | Version v1
Patent Open

Tumor specific glycoproteins and method for detecting tumorigenic cancers

Creators

Description

The detection of tumour specific glycoproteins (TSGP) in human sera often indicates the presence of a malignant tumour in a patient. The distinguishing characteristics of TSGP isolated from the blood sera of cancer patients are described in detail together with methods of TSGP isolation and purification. Details are also given of radioimmunoassay techniques capable of detecting very low levels of serum TSGP with high specificity. (U.K.)

Availability note (English)

MF available from INIS under the Report Number.

Files

13650558.pdf

Files (827.0 kB)

Name Size Download all
md5:5cb62d3355842dca9bc1cf2a176b7660
827.0 kB Preview Download

Additional details

Additional titles

Augmented title (English)
Radioimmunoassay

Publishing Information

Imprint Pagination
16 p.
IPC:
Int. Cl. C07g7/00; G01n27/26; G01n33/16; G01n33/54.
IPC
Int. Cl. C07g7/00; G01n27/26; G01n33/16; G01n33/54.
Patent number
GB patent document 1591561/A/

INIS

Country of Publication
United Kingdom
Country of Input or Organization
United Kingdom
INIS RN
13650558
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BLOOD SERUM; DIAGNOSTIC TECHNIQUES; GLYCOPROTEINS; MAN; NEOPLASMS; PURIFICATION; RADIOIMMUNOASSAY
Descriptors DEC
ANIMALS; CARBOHYDRATES; DISEASES; ISOTOPE APPLICATIONS; MAMMALS; ORGANIC COMPOUNDS; PRIMATES; PROTEINS; SACCHARIDES; TRACER TECHNIQUES; VERTEBRATES